At AseBio we want to put biotechnology at the heart of our country's recovery strategy, to drive the green transition of our economy and to strengthen our National Health System
#NewMember | "AseBio will enable us to provide differential and disruptive value"
Meet Mikrobiomik, our new member. We talk with Juan Basterra, CEO of the company
#NewMember | "AseBio is a source of new knowledge and a network of companies that integrat...
Meet PVpharm, our new member. We talk with José Alberto Ayala Ortiz, CEO of the company
Barcelona to host BIOSPAIN 2023 international conference on biotechnology
AseBio, in collaboration with Biocat, the Government of Catalonia and the Barcelona City Council, will be hosting one of...
“AseBio Investor Day 2022 showcased a bubbling biotech sector”
It’s been a week since AseBio’s event of the year, which brought together some 145 organisations and over 260...
Crowdfunding and Venture Capital: two complementary systems for private funding in the hea...
Private funding, and in this case non-bank funding, is the main funding alternative for most business projects and...
Peaches Biotech publishes positive “in vivo” results of its drug PRS CK STORM
The results show the high efficacy and safety of PRS CK STORM as a medicine to prevent and treat the cytokine storm...
El grupo Zendal adquiere el 46% de Maymó
Con esta operación, la biotecnológica gallega se convierte así en nuevo socio estratégico del grupo Maymó
The biotech sector is global and internationalization a key axis of the development of its companies. AseBio promotes major events, such as BioSpain, and since 2008 manages the 'ICEX Internationalization Plan for biotechnology companies'. Discover what we can offer you.
